BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32751497)

  • 21. LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer.
    Liu WB; Jiang X; Han F; Li YH; Chen HQ; Liu Y; Cao J; Liu JY
    Cell Death Dis; 2013 Oct; 4(10):e882. PubMed ID: 24157876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of Sp1 and EZH2 in the regulation of LMX1A in cervical cancer cells.
    Lin WC; Yan MD; Yu PN; Li HJ; Kuo CC; Hsu CL; Lin YW
    Biochim Biophys Acta; 2013 Dec; 1833(12):3206-3217. PubMed ID: 24018208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
    Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
    Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G
    Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted Therapy for Non-Small Cell Lung Cancer.
    Noor ZS; Cummings AL; Johnson MM; Spiegel ML; Goldman JW
    Semin Respir Crit Care Med; 2020 Jun; 41(3):409-434. PubMed ID: 32450595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCR4/MIF axis amplifies tumor growth and epithelial-mesenchymal interaction in non-small cell lung cancer.
    Jäger B; Klatt D; Plappert L; Golpon H; Lienenklaus S; Barbosa PD; Schambach A; Prasse A
    Cell Signal; 2020 Sep; 73():109672. PubMed ID: 32428553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms.
    Liao TT; Yang MH
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug Target.
    Chanvorachote P; Sriratanasak N; Nonpanya N
    Anticancer Res; 2020 Feb; 40(2):609-618. PubMed ID: 32014901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gefitinib promotes CXCR4-dependent epithelial to mesenchymal transition via TGF-β1 signaling pathway in lung cancer cells harboring EGFR mutation.
    Zhu Q; Zhang Z; Lu C; Xu F; Mao W; Zhang K; Shou H; Liu Z; Gu J; Ge D
    Clin Transl Oncol; 2020 Aug; 22(8):1355-1363. PubMed ID: 31900845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The SMART App: an interactive web application for comprehensive DNA methylation analysis and visualization.
    Li Y; Ge D; Lu C
    Epigenetics Chromatin; 2019 Dec; 12(1):71. PubMed ID: 31805986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells.
    Wu TH; Chang SY; Shih YL; Huang TW; Chang H; Lin YW
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LMX1A inhibits C-Myc expression through ANGPTL4 to exert tumor suppressive role in gastric cancer.
    Qian P; Li J; Zhang X; Li F; Bei S; Li H; Sun Q; Feng L
    PLoS One; 2019; 14(9):e0221640. PubMed ID: 31557193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Prognostic DNA Methylation Panel for Colorectal Cancer.
    Chung HH; Kuo CC; Hsiao CW; Chen CY; Hu JM; Hsu CH; Chou YC; Lin YW; Shih YL
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of the Phosphorylation of Transcriptional Factors in Epithelial-Mesenchymal Transition.
    Xu R; Won JY; Kim CH; Kim DE; Yim H
    J Oncol; 2019; 2019():5810465. PubMed ID: 31275381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of RASSF1A methylation status in non-small cell lung cancer (NSCLC) patients: A meta-analysis of prospective studies.
    Hu H; Zhou Y; Zhang M; Ding R
    Biomarkers; 2019 May; 24(3):207-216. PubMed ID: 30764677
    [No Abstract]   [Full Text] [Related]  

  • 36. SRGN Promotes Colorectal Cancer Metastasis as a Critical Downstream Target of HIF-1α.
    Xu Y; Xu J; Yang Y; Zhu L; Li X; Zhao W
    Cell Physiol Biochem; 2018; 48(6):2429-2440. PubMed ID: 30121667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P16
    Tuo L; Sha S; Huayu Z; Du K
    Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous, Multiplexed Detection of RNA and Protein on the NanoString
    Warren S
    Methods Mol Biol; 2018; 1783():105-120. PubMed ID: 29767359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA n335586/miR-924/CKMT1A axis contributes to cell migration and invasion in hepatocellular carcinoma cells.
    Fan H; Lv P; Mu T; Zhao X; Liu Y; Feng Y; Lv J; Liu M; Tang H
    Cancer Lett; 2018 Aug; 429():89-99. PubMed ID: 29753758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.